Found: 1
Select item for more details and to access through your institution.
Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 12, p. 2142, doi. 10.1002/ijc.34894
- By:
- Publication type:
- Article